Global Tuberculosis Vaccine Drug Market Research Report 2025(Status and Outlook)
The tuberculosis (TB) vaccine market primarily revolves around the Bacillus Calmette-Guerin (BCG) vaccine, which remains the only licensed vaccine for preventing tuberculosis, particularly severe forms in children, though its efficacy in preventing pulmonary TB in adults is variable and geographically inconsistent. This market is characterized by a high unmet medical need, especially in low- and middle-income countries with high TB burden, driving ongoing research and development efforts for next-generation vaccines aimed at improving efficacy, duration of protection, and suitability for diverse populations, including adolescents and adults. Key stakeholders include multinational pharmaceutical companies, biotech firms, non-profit organizations, and public health entities like the World Health Organization, with funding often supported by global health initiatives such as Gavi and the Stop TB Partnership. Market dynamics are influenced by factors such as government immunization policies, epidemiological trends, regulatory pathways, and the gradual progression of candidate vaccines through clinical trials, with a growing emphasis on novel platforms including viral vectors, protein subunits, and mRNA-based approaches to address the limitations of the century-old BCG vaccine.
The global Tuberculosis Vaccine Drug market size was estimated at USD 401.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tuberculosis Vaccine Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tuberculosis Vaccine Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis Vaccine Drug market.
Global Tuberculosis Vaccine Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Vaccine Drug Market
Overview of the regional outlook of the Tuberculosis Vaccine Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccine Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Vaccine Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Tuberculosis Vaccine Drug market size was estimated at USD 401.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tuberculosis Vaccine Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tuberculosis Vaccine Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis Vaccine Drug market.
Global Tuberculosis Vaccine Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Vaccine Drug Market
Overview of the regional outlook of the Tuberculosis Vaccine Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccine Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Vaccine Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tuberculosis Vaccine Drug
1.2 Key Market Segments
1.2.1 Tuberculosis Vaccine Drug Segment by Type
1.2.2 Tuberculosis Vaccine Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS VACCINE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Vaccine Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tuberculosis Vaccine Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS VACCINE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tuberculosis Vaccine Drug Product Life Cycle
3.3 Global Tuberculosis Vaccine Drug Sales by Manufacturers (2020-2025)
3.4 Global Tuberculosis Vaccine Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tuberculosis Vaccine Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tuberculosis Vaccine Drug Market Competitive Situation and Trends
3.8.1 Tuberculosis Vaccine Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tuberculosis Vaccine Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS VACCINE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Vaccine Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS VACCINE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tuberculosis Vaccine Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis Vaccine Drug Market
5.7 ESG Ratings of Leading Companies
6 TUBERCULOSIS VACCINE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025)
6.3 Global Tuberculosis Vaccine Drug Market Size Market Share by Type (2020-2025)
6.4 Global Tuberculosis Vaccine Drug Price by Type (2020-2025)
7 TUBERCULOSIS VACCINE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Vaccine Drug Market Sales by Application (2020-2025)
7.3 Global Tuberculosis Vaccine Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
8 TUBERCULOSIS VACCINE DRUG MARKET SALES BY REGION
8.1 Global Tuberculosis Vaccine Drug Sales by Region
8.1.1 Global Tuberculosis Vaccine Drug Sales by Region
8.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Region
8.2 Global Tuberculosis Vaccine Drug Market Size by Region
8.2.1 Global Tuberculosis Vaccine Drug Market Size by Region
8.2.2 Global Tuberculosis Vaccine Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Tuberculosis Vaccine Drug Sales by Country
8.3.2 North America Tuberculosis Vaccine Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tuberculosis Vaccine Drug Sales by Country
8.4.2 Europe Tuberculosis Vaccine Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tuberculosis Vaccine Drug Sales by Region
8.5.2 Asia Pacific Tuberculosis Vaccine Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tuberculosis Vaccine Drug Sales by Country
8.6.2 South America Tuberculosis Vaccine Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tuberculosis Vaccine Drug Sales by Region
8.7.2 Middle East and Africa Tuberculosis Vaccine Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUBERCULOSIS VACCINE DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Tuberculosis Vaccine Drug by Region(2020-2025)
9.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2025)
9.3 Global Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tuberculosis Vaccine Drug Production
9.4.1 North America Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.4.2 North America Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tuberculosis Vaccine Drug Production
9.5.1 Europe Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.5.2 Europe Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tuberculosis Vaccine Drug Production (2020-2025)
9.6.1 Japan Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.6.2 Japan Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tuberculosis Vaccine Drug Production (2020-2025)
9.7.1 China Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.7.2 China Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Tuberculosis Vaccine Drug Product Overview
10.1.3 Merck Tuberculosis Vaccine Drug Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Basic Information
10.2.2 Japan BCG Lab Tuberculosis Vaccine Drug Product Overview
10.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Product Market Performance
10.2.4 Japan BCG Lab Business Overview
10.2.5 Japan BCG Lab SWOT Analysis
10.2.6 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Tuberculosis Vaccine Drug Product Overview
10.3.3 Serum Institute of India Tuberculosis Vaccine Drug Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 AJ Vaccines
10.4.1 AJ Vaccines Basic Information
10.4.2 AJ Vaccines Tuberculosis Vaccine Drug Product Overview
10.4.3 AJ Vaccines Tuberculosis Vaccine Drug Product Market Performance
10.4.4 AJ Vaccines Business Overview
10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
10.5.1 BioFarma Basic Information
10.5.2 BioFarma Tuberculosis Vaccine Drug Product Overview
10.5.3 BioFarma Tuberculosis Vaccine Drug Product Market Performance
10.5.4 BioFarma Business Overview
10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Basic Information
10.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Market Performance
10.6.4 GreenSignal Bio Pharma Business Overview
10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
10.7.1 China National Biotec Basic Information
10.7.2 China National Biotec Tuberculosis Vaccine Drug Product Overview
10.7.3 China National Biotec Tuberculosis Vaccine Drug Product Market Performance
10.7.4 China National Biotec Business Overview
10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
10.8.1 Biomed Lublin Basic Information
10.8.2 Biomed Lublin Tuberculosis Vaccine Drug Product Overview
10.8.3 Biomed Lublin Tuberculosis Vaccine Drug Product Market Performance
10.8.4 Biomed Lublin Business Overview
10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Basic Information
10.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Market Performance
10.9.4 Taj Pharmaceuticals Business Overview
10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Basic Information
10.10.2 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Overview
10.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Market Performance
10.10.4 Ataulpho de Paiva Business Overview
10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Tuberculosis Vaccine Drug Product Overview
10.11.3 IVAC Tuberculosis Vaccine Drug Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Basic Information
10.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Market Performance
10.12.4 Queen Saovabha Mem. Inst Business Overview
10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
10.13.1 Microgen Basic Information
10.13.2 Microgen Tuberculosis Vaccine Drug Product Overview
10.13.3 Microgen Tuberculosis Vaccine Drug Product Market Performance
10.13.4 Microgen Business Overview
10.13.5 Microgen Recent Developments
11 TUBERCULOSIS VACCINE DRUG MARKET FORECAST BY REGION
11.1 Global Tuberculosis Vaccine Drug Market Size Forecast
11.2 Global Tuberculosis Vaccine Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tuberculosis Vaccine Drug Market Size Forecast by Country
11.2.3 Asia Pacific Tuberculosis Vaccine Drug Market Size Forecast by Region
11.2.4 South America Tuberculosis Vaccine Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis Vaccine Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tuberculosis Vaccine Drug Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tuberculosis Vaccine Drug by Type (2026-2033)
12.1.2 Global Tuberculosis Vaccine Drug Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tuberculosis Vaccine Drug by Type (2026-2033)
12.2 Global Tuberculosis Vaccine Drug Market Forecast by Application (2026-2033)
12.2.1 Global Tuberculosis Vaccine Drug Sales (K MT) Forecast by Application
12.2.2 Global Tuberculosis Vaccine Drug Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tuberculosis Vaccine Drug
1.2 Key Market Segments
1.2.1 Tuberculosis Vaccine Drug Segment by Type
1.2.2 Tuberculosis Vaccine Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS VACCINE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Vaccine Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tuberculosis Vaccine Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS VACCINE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tuberculosis Vaccine Drug Product Life Cycle
3.3 Global Tuberculosis Vaccine Drug Sales by Manufacturers (2020-2025)
3.4 Global Tuberculosis Vaccine Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tuberculosis Vaccine Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tuberculosis Vaccine Drug Market Competitive Situation and Trends
3.8.1 Tuberculosis Vaccine Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tuberculosis Vaccine Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS VACCINE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Vaccine Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS VACCINE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tuberculosis Vaccine Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis Vaccine Drug Market
5.7 ESG Ratings of Leading Companies
6 TUBERCULOSIS VACCINE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025)
6.3 Global Tuberculosis Vaccine Drug Market Size Market Share by Type (2020-2025)
6.4 Global Tuberculosis Vaccine Drug Price by Type (2020-2025)
7 TUBERCULOSIS VACCINE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Vaccine Drug Market Sales by Application (2020-2025)
7.3 Global Tuberculosis Vaccine Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
8 TUBERCULOSIS VACCINE DRUG MARKET SALES BY REGION
8.1 Global Tuberculosis Vaccine Drug Sales by Region
8.1.1 Global Tuberculosis Vaccine Drug Sales by Region
8.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Region
8.2 Global Tuberculosis Vaccine Drug Market Size by Region
8.2.1 Global Tuberculosis Vaccine Drug Market Size by Region
8.2.2 Global Tuberculosis Vaccine Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Tuberculosis Vaccine Drug Sales by Country
8.3.2 North America Tuberculosis Vaccine Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tuberculosis Vaccine Drug Sales by Country
8.4.2 Europe Tuberculosis Vaccine Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tuberculosis Vaccine Drug Sales by Region
8.5.2 Asia Pacific Tuberculosis Vaccine Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tuberculosis Vaccine Drug Sales by Country
8.6.2 South America Tuberculosis Vaccine Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tuberculosis Vaccine Drug Sales by Region
8.7.2 Middle East and Africa Tuberculosis Vaccine Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUBERCULOSIS VACCINE DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Tuberculosis Vaccine Drug by Region(2020-2025)
9.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2025)
9.3 Global Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tuberculosis Vaccine Drug Production
9.4.1 North America Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.4.2 North America Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tuberculosis Vaccine Drug Production
9.5.1 Europe Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.5.2 Europe Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tuberculosis Vaccine Drug Production (2020-2025)
9.6.1 Japan Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.6.2 Japan Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tuberculosis Vaccine Drug Production (2020-2025)
9.7.1 China Tuberculosis Vaccine Drug Production Growth Rate (2020-2025)
9.7.2 China Tuberculosis Vaccine Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Tuberculosis Vaccine Drug Product Overview
10.1.3 Merck Tuberculosis Vaccine Drug Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Basic Information
10.2.2 Japan BCG Lab Tuberculosis Vaccine Drug Product Overview
10.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Product Market Performance
10.2.4 Japan BCG Lab Business Overview
10.2.5 Japan BCG Lab SWOT Analysis
10.2.6 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Tuberculosis Vaccine Drug Product Overview
10.3.3 Serum Institute of India Tuberculosis Vaccine Drug Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 AJ Vaccines
10.4.1 AJ Vaccines Basic Information
10.4.2 AJ Vaccines Tuberculosis Vaccine Drug Product Overview
10.4.3 AJ Vaccines Tuberculosis Vaccine Drug Product Market Performance
10.4.4 AJ Vaccines Business Overview
10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
10.5.1 BioFarma Basic Information
10.5.2 BioFarma Tuberculosis Vaccine Drug Product Overview
10.5.3 BioFarma Tuberculosis Vaccine Drug Product Market Performance
10.5.4 BioFarma Business Overview
10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Basic Information
10.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Market Performance
10.6.4 GreenSignal Bio Pharma Business Overview
10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
10.7.1 China National Biotec Basic Information
10.7.2 China National Biotec Tuberculosis Vaccine Drug Product Overview
10.7.3 China National Biotec Tuberculosis Vaccine Drug Product Market Performance
10.7.4 China National Biotec Business Overview
10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
10.8.1 Biomed Lublin Basic Information
10.8.2 Biomed Lublin Tuberculosis Vaccine Drug Product Overview
10.8.3 Biomed Lublin Tuberculosis Vaccine Drug Product Market Performance
10.8.4 Biomed Lublin Business Overview
10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Basic Information
10.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Market Performance
10.9.4 Taj Pharmaceuticals Business Overview
10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Basic Information
10.10.2 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Overview
10.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Market Performance
10.10.4 Ataulpho de Paiva Business Overview
10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Tuberculosis Vaccine Drug Product Overview
10.11.3 IVAC Tuberculosis Vaccine Drug Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Basic Information
10.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Market Performance
10.12.4 Queen Saovabha Mem. Inst Business Overview
10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
10.13.1 Microgen Basic Information
10.13.2 Microgen Tuberculosis Vaccine Drug Product Overview
10.13.3 Microgen Tuberculosis Vaccine Drug Product Market Performance
10.13.4 Microgen Business Overview
10.13.5 Microgen Recent Developments
11 TUBERCULOSIS VACCINE DRUG MARKET FORECAST BY REGION
11.1 Global Tuberculosis Vaccine Drug Market Size Forecast
11.2 Global Tuberculosis Vaccine Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tuberculosis Vaccine Drug Market Size Forecast by Country
11.2.3 Asia Pacific Tuberculosis Vaccine Drug Market Size Forecast by Region
11.2.4 South America Tuberculosis Vaccine Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis Vaccine Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tuberculosis Vaccine Drug Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tuberculosis Vaccine Drug by Type (2026-2033)
12.1.2 Global Tuberculosis Vaccine Drug Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tuberculosis Vaccine Drug by Type (2026-2033)
12.2 Global Tuberculosis Vaccine Drug Market Forecast by Application (2026-2033)
12.2.1 Global Tuberculosis Vaccine Drug Sales (K MT) Forecast by Application
12.2.2 Global Tuberculosis Vaccine Drug Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Vaccine Drug Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Vaccine Drug Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Tuberculosis Vaccine Drug Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Vaccine Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2024)
Table 10. Global Market Tuberculosis Vaccine Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tuberculosis Vaccine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tuberculosis Vaccine Drug Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tuberculosis Vaccine Drug Sales by Type (K MT)
Table 26. Global Tuberculosis Vaccine Drug Market Size by Type (M USD)
Table 27. Global Tuberculosis Vaccine Drug Sales (K MT) by Type (2020-2025)
Table 28. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025)
Table 29. Global Tuberculosis Vaccine Drug Market Size (M USD) by Type (2020-2025)
Table 30. Global Tuberculosis Vaccine Drug Market Size Share by Type (2020-2025)
Table 31. Global Tuberculosis Vaccine Drug Price (USD/KG) by Type (2020-2025)
Table 32. Global Tuberculosis Vaccine Drug Sales (K MT) by Application
Table 33. Global Tuberculosis Vaccine Drug Market Size by Application
Table 34. Global Tuberculosis Vaccine Drug Sales by Application (2020-2025) & (K MT)
Table 35. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2020-2025)
Table 36. Global Tuberculosis Vaccine Drug Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tuberculosis Vaccine Drug Market Share by Application (2020-2025)
Table 38. Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
Table 39. Global Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 40. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2025)
Table 41. Global Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tuberculosis Vaccine Drug Market Size Market Share by Region (2020-2025)
Table 43. North America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 44. North America Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 46. Europe Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 50. South America Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tuberculosis Vaccine Drug Production (K MT) by Region(2020-2025)
Table 54. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2025)
Table 56. Global Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Tuberculosis Vaccine Drug Product Overview
Table 63. Merck Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Japan BCG Lab Basic Information
Table 68. Japan BCG Lab Tuberculosis Vaccine Drug Product Overview
Table 69. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Japan BCG Lab Business Overview
Table 71. Japan BCG Lab SWOT Analysis
Table 72. Japan BCG Lab Recent Developments
Table 73. Serum Institute of India Basic Information
Table 74. Serum Institute of India Tuberculosis Vaccine Drug Product Overview
Table 75. Serum Institute of India Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Serum Institute of India Business Overview
Table 77. Serum Institute of India SWOT Analysis
Table 78. Serum Institute of India Recent Developments
Table 79. AJ Vaccines Basic Information
Table 80. AJ Vaccines Tuberculosis Vaccine Drug Product Overview
Table 81. AJ Vaccines Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. AJ Vaccines Business Overview
Table 83. AJ Vaccines Recent Developments
Table 84. BioFarma Basic Information
Table 85. BioFarma Tuberculosis Vaccine Drug Product Overview
Table 86. BioFarma Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. BioFarma Business Overview
Table 88. BioFarma Recent Developments
Table 89. GreenSignal Bio Pharma Basic Information
Table 90. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Overview
Table 91. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. GreenSignal Bio Pharma Business Overview
Table 93. GreenSignal Bio Pharma Recent Developments
Table 94. China National Biotec Basic Information
Table 95. China National Biotec Tuberculosis Vaccine Drug Product Overview
Table 96. China National Biotec Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. China National Biotec Business Overview
Table 98. China National Biotec Recent Developments
Table 99. Biomed Lublin Basic Information
Table 100. Biomed Lublin Tuberculosis Vaccine Drug Product Overview
Table 101. Biomed Lublin Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Biomed Lublin Business Overview
Table 103. Biomed Lublin Recent Developments
Table 104. Taj Pharmaceuticals Basic Information
Table 105. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Overview
Table 106. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Taj Pharmaceuticals Business Overview
Table 108. Taj Pharmaceuticals Recent Developments
Table 109. Ataulpho de Paiva Basic Information
Table 110. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Overview
Table 111. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Ataulpho de Paiva Business Overview
Table 113. Ataulpho de Paiva Recent Developments
Table 114. IVAC Basic Information
Table 115. IVAC Tuberculosis Vaccine Drug Product Overview
Table 116. IVAC Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. IVAC Business Overview
Table 118. IVAC Recent Developments
Table 119. Queen Saovabha Mem. Inst Basic Information
Table 120. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Overview
Table 121. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Queen Saovabha Mem. Inst Business Overview
Table 123. Queen Saovabha Mem. Inst Recent Developments
Table 124. Microgen Basic Information
Table 125. Microgen Tuberculosis Vaccine Drug Product Overview
Table 126. Microgen Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Microgen Business Overview
Table 128. Microgen Recent Developments
Table 129. Global Tuberculosis Vaccine Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Tuberculosis Vaccine Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Tuberculosis Vaccine Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Tuberculosis Vaccine Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Tuberculosis Vaccine Drug Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Tuberculosis Vaccine Drug Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Tuberculosis Vaccine Drug Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Tuberculosis Vaccine Drug Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Tuberculosis Vaccine Drug Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Vaccine Drug Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Vaccine Drug Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Tuberculosis Vaccine Drug Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Vaccine Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2024)
Table 10. Global Market Tuberculosis Vaccine Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tuberculosis Vaccine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tuberculosis Vaccine Drug Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tuberculosis Vaccine Drug Sales by Type (K MT)
Table 26. Global Tuberculosis Vaccine Drug Market Size by Type (M USD)
Table 27. Global Tuberculosis Vaccine Drug Sales (K MT) by Type (2020-2025)
Table 28. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025)
Table 29. Global Tuberculosis Vaccine Drug Market Size (M USD) by Type (2020-2025)
Table 30. Global Tuberculosis Vaccine Drug Market Size Share by Type (2020-2025)
Table 31. Global Tuberculosis Vaccine Drug Price (USD/KG) by Type (2020-2025)
Table 32. Global Tuberculosis Vaccine Drug Sales (K MT) by Application
Table 33. Global Tuberculosis Vaccine Drug Market Size by Application
Table 34. Global Tuberculosis Vaccine Drug Sales by Application (2020-2025) & (K MT)
Table 35. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2020-2025)
Table 36. Global Tuberculosis Vaccine Drug Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tuberculosis Vaccine Drug Market Share by Application (2020-2025)
Table 38. Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
Table 39. Global Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 40. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2025)
Table 41. Global Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tuberculosis Vaccine Drug Market Size Market Share by Region (2020-2025)
Table 43. North America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 44. North America Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 46. Europe Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K MT)
Table 50. South America Tuberculosis Vaccine Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Tuberculosis Vaccine Drug Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tuberculosis Vaccine Drug Production (K MT) by Region(2020-2025)
Table 54. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2025)
Table 56. Global Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Tuberculosis Vaccine Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Tuberculosis Vaccine Drug Product Overview
Table 63. Merck Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Japan BCG Lab Basic Information
Table 68. Japan BCG Lab Tuberculosis Vaccine Drug Product Overview
Table 69. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Japan BCG Lab Business Overview
Table 71. Japan BCG Lab SWOT Analysis
Table 72. Japan BCG Lab Recent Developments
Table 73. Serum Institute of India Basic Information
Table 74. Serum Institute of India Tuberculosis Vaccine Drug Product Overview
Table 75. Serum Institute of India Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Serum Institute of India Business Overview
Table 77. Serum Institute of India SWOT Analysis
Table 78. Serum Institute of India Recent Developments
Table 79. AJ Vaccines Basic Information
Table 80. AJ Vaccines Tuberculosis Vaccine Drug Product Overview
Table 81. AJ Vaccines Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. AJ Vaccines Business Overview
Table 83. AJ Vaccines Recent Developments
Table 84. BioFarma Basic Information
Table 85. BioFarma Tuberculosis Vaccine Drug Product Overview
Table 86. BioFarma Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. BioFarma Business Overview
Table 88. BioFarma Recent Developments
Table 89. GreenSignal Bio Pharma Basic Information
Table 90. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Overview
Table 91. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. GreenSignal Bio Pharma Business Overview
Table 93. GreenSignal Bio Pharma Recent Developments
Table 94. China National Biotec Basic Information
Table 95. China National Biotec Tuberculosis Vaccine Drug Product Overview
Table 96. China National Biotec Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. China National Biotec Business Overview
Table 98. China National Biotec Recent Developments
Table 99. Biomed Lublin Basic Information
Table 100. Biomed Lublin Tuberculosis Vaccine Drug Product Overview
Table 101. Biomed Lublin Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Biomed Lublin Business Overview
Table 103. Biomed Lublin Recent Developments
Table 104. Taj Pharmaceuticals Basic Information
Table 105. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Overview
Table 106. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Taj Pharmaceuticals Business Overview
Table 108. Taj Pharmaceuticals Recent Developments
Table 109. Ataulpho de Paiva Basic Information
Table 110. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Overview
Table 111. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Ataulpho de Paiva Business Overview
Table 113. Ataulpho de Paiva Recent Developments
Table 114. IVAC Basic Information
Table 115. IVAC Tuberculosis Vaccine Drug Product Overview
Table 116. IVAC Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. IVAC Business Overview
Table 118. IVAC Recent Developments
Table 119. Queen Saovabha Mem. Inst Basic Information
Table 120. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Overview
Table 121. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Queen Saovabha Mem. Inst Business Overview
Table 123. Queen Saovabha Mem. Inst Recent Developments
Table 124. Microgen Basic Information
Table 125. Microgen Tuberculosis Vaccine Drug Product Overview
Table 126. Microgen Tuberculosis Vaccine Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Microgen Business Overview
Table 128. Microgen Recent Developments
Table 129. Global Tuberculosis Vaccine Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Tuberculosis Vaccine Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Tuberculosis Vaccine Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Tuberculosis Vaccine Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Tuberculosis Vaccine Drug Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Tuberculosis Vaccine Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Tuberculosis Vaccine Drug Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Tuberculosis Vaccine Drug Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Tuberculosis Vaccine Drug Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Tuberculosis Vaccine Drug Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Tuberculosis Vaccine Drug Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tuberculosis Vaccine Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Vaccine Drug Market Size (M USD), 2024-2033
Figure 5. Global Tuberculosis Vaccine Drug Market Size (M USD) (2020-2033)
Figure 6. Global Tuberculosis Vaccine Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Vaccine Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tuberculosis Vaccine Drug Product Life Cycle
Figure 13. Tuberculosis Vaccine Drug Sales Share by Manufacturers in 2024
Figure 14. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers in 2024
Figure 15. Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tuberculosis Vaccine Drug Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Vaccine Drug Revenue in 2024
Figure 18. Industry Chain Map of Tuberculosis Vaccine Drug
Figure 19. Global Tuberculosis Vaccine Drug Market PEST Analysis
Figure 20. Global Tuberculosis Vaccine Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tuberculosis Vaccine Drug Market Share by Type
Figure 27. Sales Market Share of Tuberculosis Vaccine Drug by Type (2020-2025)
Figure 28. Sales Market Share of Tuberculosis Vaccine Drug by Type in 2024
Figure 29. Market Size Share of Tuberculosis Vaccine Drug by Type (2020-2025)
Figure 30. Market Size Share of Tuberculosis Vaccine Drug by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tuberculosis Vaccine Drug Market Share by Application
Figure 33. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Tuberculosis Vaccine Drug Sales Market Share by Application in 2024
Figure 35. Global Tuberculosis Vaccine Drug Market Share by Application (2020-2025)
Figure 36. Global Tuberculosis Vaccine Drug Market Share by Application in 2024
Figure 37. Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Tuberculosis Vaccine Drug Market Size Market Share by Region (2020-2025)
Figure 40. North America Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 43. North America Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 45. U.S. Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tuberculosis Vaccine Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tuberculosis Vaccine Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tuberculosis Vaccine Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tuberculosis Vaccine Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 53. Europe Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 55. Germany Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tuberculosis Vaccine Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tuberculosis Vaccine Drug Market Size Market Share by Region in 2024
Figure 68. China Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 79. South America Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 80. South America Tuberculosis Vaccine Drug Market Size and Growth Rate (M USD)
Figure 81. South America Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 82. Brazil Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tuberculosis Vaccine Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tuberculosis Vaccine Drug Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tuberculosis Vaccine Drug Production Market Share by Region (2020-2025)
Figure 103. North America Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tuberculosis Vaccine Drug Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Tuberculosis Vaccine Drug Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tuberculosis Vaccine Drug Market Share Forecast by Type (2026-2033)
Figure 111. Global Tuberculosis Vaccine Drug Sales Forecast by Application (2026-2033)
Figure 112. Global Tuberculosis Vaccine Drug Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Tuberculosis Vaccine Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Vaccine Drug Market Size (M USD), 2024-2033
Figure 5. Global Tuberculosis Vaccine Drug Market Size (M USD) (2020-2033)
Figure 6. Global Tuberculosis Vaccine Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Vaccine Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tuberculosis Vaccine Drug Product Life Cycle
Figure 13. Tuberculosis Vaccine Drug Sales Share by Manufacturers in 2024
Figure 14. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers in 2024
Figure 15. Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tuberculosis Vaccine Drug Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Vaccine Drug Revenue in 2024
Figure 18. Industry Chain Map of Tuberculosis Vaccine Drug
Figure 19. Global Tuberculosis Vaccine Drug Market PEST Analysis
Figure 20. Global Tuberculosis Vaccine Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tuberculosis Vaccine Drug Market Share by Type
Figure 27. Sales Market Share of Tuberculosis Vaccine Drug by Type (2020-2025)
Figure 28. Sales Market Share of Tuberculosis Vaccine Drug by Type in 2024
Figure 29. Market Size Share of Tuberculosis Vaccine Drug by Type (2020-2025)
Figure 30. Market Size Share of Tuberculosis Vaccine Drug by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tuberculosis Vaccine Drug Market Share by Application
Figure 33. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Tuberculosis Vaccine Drug Sales Market Share by Application in 2024
Figure 35. Global Tuberculosis Vaccine Drug Market Share by Application (2020-2025)
Figure 36. Global Tuberculosis Vaccine Drug Market Share by Application in 2024
Figure 37. Global Tuberculosis Vaccine Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Tuberculosis Vaccine Drug Market Size Market Share by Region (2020-2025)
Figure 40. North America Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 43. North America Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 45. U.S. Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tuberculosis Vaccine Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tuberculosis Vaccine Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tuberculosis Vaccine Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tuberculosis Vaccine Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 53. Europe Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 55. Germany Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tuberculosis Vaccine Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tuberculosis Vaccine Drug Market Size Market Share by Region in 2024
Figure 68. China Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 79. South America Tuberculosis Vaccine Drug Sales Market Share by Country in 2024
Figure 80. South America Tuberculosis Vaccine Drug Market Size and Growth Rate (M USD)
Figure 81. South America Tuberculosis Vaccine Drug Market Size Market Share by Country in 2024
Figure 82. Brazil Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tuberculosis Vaccine Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tuberculosis Vaccine Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tuberculosis Vaccine Drug Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tuberculosis Vaccine Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tuberculosis Vaccine Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tuberculosis Vaccine Drug Production Market Share by Region (2020-2025)
Figure 103. North America Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tuberculosis Vaccine Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tuberculosis Vaccine Drug Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Tuberculosis Vaccine Drug Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tuberculosis Vaccine Drug Market Share Forecast by Type (2026-2033)
Figure 111. Global Tuberculosis Vaccine Drug Sales Forecast by Application (2026-2033)
Figure 112. Global Tuberculosis Vaccine Drug Market Share Forecast by Application (2026-2033)
